BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Opko Health
OPK
$1.11B
| $279K | ﹤0.01% |
81,930
-137,665
| -63% | -$469K |
|
|
MTOR
1627
DELISTED
MERITOR, Inc.
MTOR
| $278K | ﹤0.01% |
14,020
-21,541
| -61% | -$427K |
|
1628
Boise Cascade
BCC
$3.2B
| $277K | ﹤0.01% |
7,356
-11,761
| -62% | -$442K |
|
1629
NeoGenomics
NEO
$1.03B
| $275K | ﹤0.01% |
8,888
-32,205
| -78% | -$998K |
|
1630
Azenta
AZTA
$1.36B
| $275K | ﹤0.01% |
6,209
-24,020
| -79% | -$1.06M |
|
1631
Corcept Therapeutics
CORT
$7.68B
| $275K | ﹤0.01% |
16,327
-41,638
| -72% | -$700K |
|
1632
ProShares Short VIX Short-Term Futures ETF
SVXY
$254M
| $275K | ﹤0.01% |
17,436
| – | – |
|
1633
Northwest Natural Holdings
NWN
$1.73B
| $274K | ﹤0.01% |
4,919
-7,881
| -62% | -$440K |
|
|
CVA
1634
DELISTED
Covanta Holding Corporation
CVA
| $274K | ﹤0.01% |
28,528
-33,155
| -54% | -$318K |
|
|
B
1635
DELISTED
Barnes Group Inc.
B
| $273K | ﹤0.01% |
6,899
-32,958
| -83% | -$1.3M |
|
1636
Cadence Bank
CADE
$7.02B
| $272K | ﹤0.01% |
11,980
-5,293
| -31% | -$120K |
|
1637
ING
ING
$74.7B
| $269K | ﹤0.01% |
38,996
+2,931
| +8% | +$20.2K |
|
|
SWN
1638
DELISTED
Southwestern Energy Company
SWN
| $268K | ﹤0.01% |
104,601
-128,510
| -55% | -$329K |
|
1639
8x8 Inc
EGHT
$286M
| $268K | ﹤0.01% |
16,733
-159,362
| -90% | -$2.55M |
|
1640
ODP
ODP
$624M
| $267K | ﹤0.01% |
11,374
-11,588
| -50% | -$272K |
|
1641
Owens & Minor
OMI
$412M
| $267K | ﹤0.01% |
35,046
+6,318
| +22% | +$48.1K |
|
|
PRTY
1642
DELISTED
Party City Holdco Inc.
PRTY
| $267K | ﹤0.01% |
179,067
-150,058
| -46% | -$224K |
|
|
CNH
1643
CNH Industrial
CNH
$13.7B
| $266K | ﹤0.01% |
43,483
+917
| +2% | +$5.61K |
|
1644
Performance Food Group
PFGC
$16.6B
| $266K | ﹤0.01% |
9,113
-62,104
| -87% | -$1.81M |
|
1645
Sanofi
SNY
$115B
| $265K | ﹤0.01% |
5,184
-22,251
| -81% | -$1.14M |
|
1646
Cleveland-Cliffs
CLF
$5.78B
| $264K | ﹤0.01% |
47,869
-204,895
| -81% | -$1.13M |
|
|
CIT
1647
DELISTED
CIT Group Inc.
CIT
| $263K | ﹤0.01% |
12,692
-102,268
| -89% | -$2.12M |
|
|
IAA
1648
DELISTED
IAA, Inc. Common Stock
IAA
| $262K | ﹤0.01% |
6,792
-242,895
| -97% | -$9.37M |
|
|
PGRE
1649
Paramount Group
PGRE
$1.57B
| $261K | ﹤0.01% |
33,897
+3,010
| +10% | +$23.2K |
|
1650
Carter's
CRI
$1.08B
| $261K | ﹤0.01% |
3,229
+446
| +16% | +$36K |
|